Risk factors for pulmonary metastasis in patients with hepatocellular carcinoma
LUO Xiao-wei, ZHOU Li-jiang, XU Chong
2025, 30(2):
226-230.
Asbtract
(
23 )
PDF (427KB)
(
4
)
References |
Related Articles |
Metrics
Objective To evaluate the risk factors and serological indexes related to lung metastasis in patients with hepatocellular carcinoma (HCC), and to provide reference for early diagnosis and treatment of HCC lung metastasis and improvement of prognosis. Methods A total of 128 HCC patients admitted to Xishan District Hospital of Traditional Chinese Medicine of Wuxi City from January 2020 to December 2023 were involved and divided into lung metastasis group (n=37) and no lung metastasis group (n=81) according to whether lung metastasis occurred within 2 years of diagnosis and treatment. The baseline data and clinical indicators of the subjects were collected and compared, and the risk factors of lung metastasis in HCC were analyzed by logistic multivariate regression. The receiver operating curve (ROC) was plotted to analyze risk factors and the estimated value of the predictive model. Results The preoperative history of CHB, tumor diameter > 5 cm, number of tumors > 2, presence of PVTT and cirrhosis, proportion of non-operative treatment and NLR, ALBI, AFP-L3 and PIVKA-Ⅱ levels were 72.97%, 51.35%, 56.76%, 67.57%, 59.46% and 70.27, respectively %, 0.29, -1.86, 95.49±11.27 μg/L, 548.16±65.34 mAU/mL, They were higher than those in the group without lung metastasis (51.85%, 29.63%, 33.33%, 34.57%, 37.04, 53.09%, 0.42, -3.28, 45.16±6.45 μg/L, 207.35±26.09 mAU/mL), and the difference was statistically significant (t/χ2/Z=3.762, 4.084,3.917,4.526, 4.073, 3.659, 7.268, 9.436, 11.264, 13.538 were all P<0.05). Logistics regression analysis showed that CHB history and PVTT existed before surgery, increased levels of NLR, ALBI, AFP-L3 and PIVKA-Ⅱ were independent factors for lung metastasis in HCC patients (95%CI: 0.905 ~ 1.126, 0.751 ~ 0.863, 0.816 ~ 1.274, 0.875 ~ 1.427, 1.034 ~ 1.568, 0.843 ~ 1). 369, OR=0.934, 0.803, 1.024, 1.126, 1.359, 1.107, all P<0.05). ROC analysis showed that the area under the curve (AUC) of preoperative CHB history and PVTT, NLR, ALBI, AFP-L3 and PIVKA-Ⅱ levels were 0.709, 0.725, 0.817, 0.810, 0.881 and 0.852, respectively. The sensitivity was 70.27%, 81.08%, 86.49%, 83.78%, 94.59%, 89.19%, and the specificity was 64.86%, 67.57%, 78.38%, 72.97%, 83.78%, 91.89% (all P<0.01). Conclusion Preoperative history of CHB and abnormal elevation of PVTT, NLR, ALBI, AFP-L3 and PIVKA-Ⅱ levels in HCC patients are independent risk factors for lung metastasis, which can provide a reference for early warning, diagnosis and treatment and prognosis evaluation.